Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The interaction between GABA and dopamine: implications for schizophrenia.

J C Garbutt, D P van Kammen

    Schizophrenia Bulletin
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.

    Alcohol and alcoholism (Oxford, Oxfordshire)·2019
    Same author

    Centrally-mediated sensory information processing is impacted with increased alcohol consumption in college-aged individuals.

    Brain research·2012
    Same author

    Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses.

    Psychopharmacology·2005
    Same author

    Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia.

    Prostaglandins, leukotrienes, and essential fatty acids·2003
    Same author

    Characterization of human cleaved N-CAM and association with schizophrenia.

    Experimental neurology·2001
    Same author

    Neuroleptic effects on autonomic activity in schizophrenia: between-group and within-subject paradigms and comparisons with controls.

    Schizophrenia bulletin·2001
    Same journal

    Reconsidering the Term "Treatment Resistant Schizophrenia".

    Schizophrenia bulletin·2026
    Same journal

    The Effect of Semaglutide on Antipsychotic-Induced Weight Gain and Other Metabolic Parameters, among a Cohort of Inpatients.

    Schizophrenia bulletin·2026
    Same journal

    Comparing Apples to Oranges Obscures Tortoises Beating Hares: The Relationship Between Rate of Antipsychotic Tapering and Relapse.

    Schizophrenia bulletin·2026
    Same journal

    Beyond the Need for Speed: D2 Receptor Affinity Predicts Relapse after Antipsychotic Tapering in First Episode Psychosis.

    Schizophrenia bulletin·2026
    Same journal

    Correction to: The Mini-CAARMS: Development and Validation of a Short Version of the Comprehensive Assessment of AT Risk Mental States to Facilitate Preventive Psychiatry.

    Schizophrenia bulletin·2026
    Same journal

    Longitudinal Impact of Birthweight and its Polygenic Risk Score on Glucose and Antipsychotic-Induced Weight Gain in First Episode Psychosis.

    Schizophrenia bulletin·2026
    See all related articles

    Research into gamma-aminobutyric acid (GABA) and schizophrenia shows inconsistent findings. Despite early hopes for GABA as a treatment, its complex role and challenges in study have hindered progress, though promising avenues remain.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Biochemistry

    Background:

    • The role of gamma-aminobutyric acid (GABA) in schizophrenia pathophysiology was proposed in 1972.
    • Initial hypotheses suggested GABA could treat schizophrenia by inhibiting dopaminergic activity.

    Purpose of the Study:

    • To review the existing literature on GABA and schizophrenia.
    • To explore the complex relationship between GABA and dopaminergic functions in schizophrenia models.
    • To identify challenges and promising future research directions.

    Main Methods:

    • Review of biochemical and pharmacological studies on GABA in schizophrenia.
    • Analysis of research on GABA's interaction with dopaminergic systems.
    • Discussion of methodological limitations in studying the GABA system.

    Related Experiment Videos

    Main Results:

    • Despite extensive research, no clear, reproducible GABA disturbance has been identified in schizophrenia.
    • Recent data suggest GABA may have opposing effects on dopaminergic functions in certain models.
    • Difficulties in studying GABA include the lack of specific agonists and the system's complexity.

    Conclusions:

    • The direct link between GABA system dysfunction and schizophrenia remains elusive.
    • Challenges in GABA research have led to waning interest, but potential clinical investigations persist.
    • Further research is needed to clarify GABA's role and therapeutic potential in schizophrenia.